TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ICLR

ICON PLC

Healthcare · Diagnostics & Research

175.60$ +1.9% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns ICON PLC (ICLR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.9% of the shares are freely tradable; institutional investors hold 107.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 107.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 77Mio.

Largest Shareholders

Institutions

Institutions ICLR
Name Stake (%) Shares Change (%) Date
Artisan Partners Limited Partnership 11.19 8,636,406 +4.3 06/30/2026
Wellington Management Company LLP 6.90 5,320,054 -10.0 06/30/2026
Harris Associates L.P. 5.79 4,468,146 +2.7 06/30/2026
FMR Inc 5.41 4,174,006 +34.7 03/31/2026
Amvescap Plc. 5.03 3,878,869 +3.2 03/31/2026
Brave Warrior Advisors LLC 4.09 3,153,308 +5.2 06/30/2026
Greenhaven Associates Inc 4.02 3,100,615 +54.8 06/30/2026
Principal Financial Group Inc 3.82 2,950,974 -10.9 06/30/2026

Funds

Funds ICLR
Name Stake (%) Shares Change (%) Date
Artisan International Value 8.74 6,744,902 +6.7 06/30/2026
Artisan International Value Investor 8.74 6,744,902 +6.7 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ICLR
Person Role Shares Value As of Type
Murray Ciaran Director 20,452 3,591,371 $ Aug 11, 2026 direct
Grais Linda Director 6,162 1,082,047 $ Aug 11, 2026 direct
Clerkin Nigel Bernard John Chief Financial Officer 5,881 1,032,704 $ Aug 11, 2026 direct
Murphy Ronan Martin Director 3,847 675,533 $ Sep 17, 2026 direct
McCague Eugene Pacelli Director 3,811 669,212 $ Sep 17, 2026 direct
O'Neill Julie Director 3,515 617,234 $ Aug 11, 2026 direct
Climax John Dr Director 2,087 366,477 $ Sep 16, 2026 direct
Whitaker Anne Clem Director 891 156,460 $ Aug 11, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 17, 2026 McCague Eugene Pacelli Director Sell 3,255 175.00 569,625
Sep 17, 2026 McCague Eugene Pacelli Director Other 3,255 125.74 409,284
Sep 17, 2026 Murphy Ronan Martin Director Sell 5,005 175.00 875,875
Sep 17, 2026 Murphy Ronan Martin Director Other 5,005 125.74 629,329
Sep 16, 2026 Climax John Dr Director Sell 5,005 175.00 875,875
Sep 16, 2026 Climax John Dr Director Other 5,005 125.74 629,329
Aug 11, 2026 Whitaker Anne Clem Director Sell 67 165.51 11,089
Aug 11, 2026 Whitaker Anne Clem Director Sell 590 164.47 97,037
Aug 11, 2026 Whitaker Anne Clem Director Sell 96 163.77 15,722
Aug 11, 2026 Whitaker Anne Clem Director Sell 88 162.72 14,319
Aug 11, 2026 O'Neill Julie Director Sell 73 165.51 12,082
Aug 11, 2026 O'Neill Julie Director Sell 642 164.47 105,590
Aug 11, 2026 O'Neill Julie Director Sell 105 163.77 17,196
Aug 11, 2026 O'Neill Julie Director Sell 95 162.72 15,458
Aug 11, 2026 Murray Ciaran Director Sell 212 165.51 35,088
Aug 11, 2026 Murray Ciaran Director Sell 1,880 164.47 309,204
Aug 11, 2026 Murray Ciaran Director Sell 305 163.77 49,950
Aug 11, 2026 Murray Ciaran Director Sell 280 162.72 45,562
Aug 11, 2026 Murphy Ronan Martin Director Sell 67 165.51 11,089
Aug 11, 2026 Murphy Ronan Martin Director Sell 590 164.47 97,037
Aug 11, 2026 Murphy Ronan Martin Director Sell 96 163.77 15,722
Aug 11, 2026 Murphy Ronan Martin Director Sell 88 162.72 14,319
Aug 11, 2026 McCague Eugene Pacelli Director Sell 67 165.51 11,089
Aug 11, 2026 McCague Eugene Pacelli Director Sell 590 164.47 97,037
Aug 11, 2026 McCague Eugene Pacelli Director Sell 96 163.77 15,722
Aug 11, 2026 McCague Eugene Pacelli Director Sell 88 162.72 14,319
Aug 11, 2026 Grais Linda Director Sell 67 165.51 11,089
Aug 11, 2026 Grais Linda Director Sell 590 164.47 97,037
Aug 11, 2026 Grais Linda Director Sell 97 163.77 15,886
Aug 11, 2026 Grais Linda Director Sell 87 162.72 14,157
Aug 11, 2026 Climax John Dr Director Sell 67 165.51 11,089
Aug 11, 2026 Climax John Dr Director Sell 591 164.47 97,202
Aug 11, 2026 Climax John Dr Director Sell 95 163.77 15,558
Aug 11, 2026 Climax John Dr Director Sell 88 162.72 14,319
Aug 11, 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 180 165.51 29,792
Aug 11, 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 1,591 164.47 261,672
Aug 11, 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 259 163.77 42,416
Aug 11, 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 237 162.72 38,565
Aug 10, 2026 Whitaker Anne Clem Director Other 1,732 – –
Aug 10, 2026 O'Neill Julie Director Other 1,732 – –
Aug 10, 2026 Murray Ciaran Director Other 2,677 – –
Aug 10, 2026 Murphy Ronan Martin Director Other 1,732 – –
Aug 10, 2026 McCague Eugene Pacelli Director Other 1,732 – –
Aug 10, 2026 Grais Linda Director Other 1,732 – –
Aug 10, 2026 Climax John Dr Director Other 1,732 – –
Aug 10, 2026 Clerkin Nigel Bernard John Chief Financial Officer Other 3,375 – –
Aug 10, 2026 Clerkin Nigel Bernard John Chief Financial Officer Other 918 – –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?